arrow
L

Luca Biasco

sana biotechnology, inc.
H指数:25
被引数:5,705

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles

使用包膜工程病毒样颗粒对人类造血干细胞和祖细胞进行体内基因编辑

2025-12-050
PRE
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations
2024-11-010
OAAI
Lentiviral gene therapy for X-linked chronic granulomatous disease
2020-01-27169
OAAI
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
2019-05-01155
OAAI
Highly efficient therapeutic gene editing of human hematopoietic stem cells

人类造血干细胞的高效治疗性基因编辑

2019-03-25365
OAAI
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases
2016-07-01213
OAAI
Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (vol 21, pg 175, 2013)
2016-06-010
OA
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory
2015-12-0998
PREAI